BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg. 2004;28:247-253. [PMID: 14961197 DOI: 10.1007/s00268-003-7191-5] [Cited by in Crossref: 167] [Cited by in F6Publishing: 155] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Archetti M. Evolutionary dynamics of the Warburg effect: Glycolysis as a collective action problem among cancer cells. Journal of Theoretical Biology 2014;341:1-8. [DOI: 10.1016/j.jtbi.2013.09.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
2 Nakagawa M, Choi YY, An JY, Chung H, Seo SH, Shin HB, Bang HJ, Li S, Kim HI, Cheong JH. Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study. BMC Cancer. 2015;15:943. [PMID: 26625983 DOI: 10.1186/s12885-015-1940-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
3 Tang L, Wang XJ, Baba H, Giganti F. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and 18F-FDG PET/CT findings. Eur Radiol 2020;30:247-60. [PMID: 31392480 DOI: 10.1007/s00330-019-06370-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
4 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 407] [Article Influence: 48.8] [Reference Citation Analysis]
5 Yoon NR, Park JM, Jung HS, Cho YK, Lee IS, Choi M, Chung I, Song KY, Park CH. Usefulness of 18 F-fluoro-2-deoxyglucose Positron Emission Tomography in Evaluation of Gastric Cancer Stage. Korean J Gastroenterol 2012;59:347. [DOI: 10.4166/kjg.2012.59.5.347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Song J, Li Z, Chen P, Yu J, Wang F, Yang Z, Wang X. A 18FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer. Chin J Cancer Res 2019;31:632-40. [PMID: 31564806 DOI: 10.21147/j.issn.1000-9604.2019.04.07] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Hundahl SA. Surgery for gastric cancer: what the trials indicate. Surg Oncol Clin N Am 2012;21:79-97. [PMID: 22098833 DOI: 10.1016/j.soc.2011.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Gertsen EC, Brenkman HJF, van Hillegersberg R, van Sandick JW, van Berge Henegouwen MI, Gisbertz SS, Luyer MDP, Nieuwenhuijzen GAP, van Lanschot JJB, Lagarde SM, Wijnhoven BPL, de Steur WO, Hartgrink HH, Stoot JHMB, Hulsewe KWE, Spillenaar Bilgen EJ, van Det MJ, Kouwenhoven EA, van der Peet DL, Daams F, van Grieken NCT, Heisterkamp J, van Etten B, van den Berg JW, Pierie JP, Eker HH, Thijssen AY, Belt EJT, van Duijvendijk P, Wassenaar E, van Laarhoven HWM, Wevers KP, Hol L, Wessels FJ, Haj Mohammad N, van der Meulen MP, Frederix GWJ, Vegt E, Siersema PD, Ruurda JP; PLASTIC Study Group. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC). JAMA Surg 2021;:e215340. [PMID: 34705049 DOI: 10.1001/jamasurg.2021.5340] [Reference Citation Analysis]
9 Ott K, Herrmann K, Schuster T, Langer R, Becker K, Wieder HA, Wester HJ, Siewert JR, zum Büschenfelde CM, Buck AK. Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer. Ann Surg Oncol. 2011;18:3316-3323. [PMID: 21537865 DOI: 10.1245/s10434-011-1743-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
10 Kaneko Y, Murray WK, Link E, Hicks RJ, Duong C. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer. J Nucl Med. 2015;56:523-529. [PMID: 25745094 DOI: 10.2967/jnumed.114.150946] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
11 Takebayashi R, Izuishi K, Yamamoto Y, Kameyama R, Mori H, Masaki T, Suzuki Y. [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer. J Exp Clin Cancer Res. 2013;32:34. [PMID: 23718763 DOI: 10.1186/1756-9966-32-34] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
12 Jeong J, Cho I, Kong E, Chun K, Jang B, Kim T, Kim S, Song S. Evaluation of hybrid PET/CT gastrography in gastric cancer. Nuklearmedizin 2013;52:107-12. [PMID: 23681152 DOI: 10.3413/Nukmed-0504-12-05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
13 Sedoris KC, Thomas SD, Miller DM. c-myc Promoter Binding Protein Regulates the Cellular Response to an Altered Glucose Concentration. Biochemistry 2007;46:8659-68. [DOI: 10.1021/bi7003558] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
14 Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW, Tuttle RM, Drucker W, Larson SM. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2006;91:498-505. [PMID: 16303836 DOI: 10.1210/jc.2005-1534] [Cited by in Crossref: 389] [Cited by in F6Publishing: 285] [Article Influence: 22.9] [Reference Citation Analysis]
15 Lee M, Yeum TS, Kim JW, Oh S, Lee SA, Moon HR, Choi YH, Han YM, Choi JM, Jang DK. Recent chemotherapy reduces the maximum-standardized uptake value of 18F-fluoro-deoxyglucose positron emission tomography in colorectal cancer. Gut Liver 2014;8:254-64. [PMID: 24827621 DOI: 10.5009/gnl.2014.8.3.254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Kruijff S, Bastiaannet E, Speijers M, Kobold A, Brouwers A, Hoekstra H. The value of pre operative S-100B and SUV in clinically stage III melanoma patients undergoing therapeutic lymph node dissection. European Journal of Surgical Oncology (EJSO) 2011;37:225-32. [DOI: 10.1016/j.ejso.2010.12.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
17 Youn SH, Seo KW, Lee SH, Shin YM, Yoon KY. 18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography: Computed Tomography for Preoperative Staging in Gastric Cancer Patients. J Gastric Cancer. 2012;12:179-186. [PMID: 23094230 DOI: 10.5230/jgc.2012.12.3.179] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
18 Shimada H, Okazumi S, Koyama M, Murakami K. Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer. 2011;14:13-21. [PMID: 21331531 DOI: 10.1007/s10120-011-0017-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.4] [Reference Citation Analysis]
19 Shoda H, Kakugawa Y, Saito D, Kozu T, Terauchi T, Daisaki H, Hamashima C, Muramatsu Y, Moriyama N, Saito H. Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy. Br J Cancer. 2007;97:1493-1498. [PMID: 18040274 DOI: 10.1038/sj.bjc.6604062] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
20 Bastiaannet E, Hoekstra OS, Oyen WJG, Jager PL, Wobbes T, Hoekstra HJ. Level of Fluorodeoxyglucose Uptake Predicts Risk for Recurrence in Melanoma Patients Presenting With Lymph Node Metastases. Ann Surg Oncol 2006;13:919-26. [DOI: 10.1245/aso.2006.02.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
21 Ott K, Lordick F, Herrmann K, Krause BJ, Schuhmacher C, Siewert JR. The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies. Gastric Cancer. 2008;11:1-9. [PMID: 18373171 DOI: 10.1007/s10120-007-0448-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
22 Chung HW, Lee EJ, Cho YH, Yoon SY, So Y, Kim SY, Lee MH, Kim JH, Lee SY, Sung IK, Park HS, Yoo MW, Lee KY. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma. J Cancer Res Clin Oncol 2010;136:1929-35. [PMID: 20306088 DOI: 10.1007/s00432-010-0852-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
23 Li XF, Fu Q, Dong YW, Liu JJ, Song XY, Dai D, Zuo C, Xu WG. 18F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma. World J Gastroenterol 2016; 22(34): 7787-7796 [PMID: 27678362 DOI: 10.3748/wjg.v22.i34.7787] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Zhu Z, Li F, Zhuang H. Gastric distension by ingesting food is useful in the evaluation of primary gastric cancer by FDG PET. Clin Nucl Med. 2007;32:106-109. [PMID: 17242562 DOI: 10.1097/01.rlu.0000252181.76139.5e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
25 Małkowski B, Staniuk T, Srutek E, Gorycki T, Zegarski W, Studniarek M. (18)F-FLT PET/CT in Patients with Gastric Carcinoma. Gastroenterol Res Pract 2013;2013:696423. [PMID: 24454342 DOI: 10.1155/2013/696423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
26 Jo HJ, Kim SJ, Lee HY, Kim IJ. Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET/CT in patients with surgically resected rectal cancer. Clin Nucl Med 2014;39:493-7. [PMID: 24806602 DOI: 10.1097/RLU.0000000000000438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
27 Wu J, Zhu H, Li K, Wang XG, Gui Y, Lu GM. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings of gastric lymphoma: Comparisons with gastric cancer. Oncol Lett. 2014;8:1757-1764. [PMID: 25202405 DOI: 10.3892/ol.2014.2412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
28 Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E, Hölscher AH. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun. 2010;31:532-538. [PMID: 20220543 DOI: 10.1097/mnm.0b013e32833823ac] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
29 Bosch KD, Chicklore S, Cook GJ, Davies AR, Kelly M, Gossage JA, Baker CR. Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment. Eur J Nucl Med Mol Imaging 2020;47:759-67. [PMID: 31377821 DOI: 10.1007/s00259-019-04429-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Chin BB, Chang PP. Gastrointestinal malignancies evaluated with 18F-fluoro-2-deoxyglucose positron emission tomography. Best Practice & Research Clinical Gastroenterology 2006;20:3-21. [DOI: 10.1016/j.bpg.2005.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kühl H. Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging. 2006;31:25-35. [PMID: 16333707 DOI: 10.1007/s00261-005-0031-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
32 Furukawa H, Ikuma H, Asakura K, Uesaka K. Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma. J Surg Oncol. 2009;100:494-499. [PMID: 19653260 DOI: 10.1002/jso.21356] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
33 Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, Okuyama C, Oguchi K, Kawamoto M, Suzuki Y, Tsukamoto E, Terauchi T, Nakashima R, Nishio M, Nishizawa S, Fukuda H, Yoshida T, Inoue T. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey. Ann Nucl Med 2007;21:481-98. [PMID: 18030580 DOI: 10.1007/s12149-007-0061-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
34 Nakamura Y, Shimazoe K, Takahashi H. Design and fabrication of endoscope-type Compton camera. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 2013;731:283-7. [DOI: 10.1016/j.nima.2013.06.100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Hustinx R. PET imaging in assessing gastrointestinal tumors. Radiologic Clinics of North America 2004;42:1123-39. [DOI: 10.1016/j.rcl.2004.08.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
36 Kajiya Y, Tani A, Shimaoka S, Tanaka S, Nakajo M. Early Gastric Cancer Detected by 2-Hour Delayed FDG PET With the Water Gastric Distention Method. Clinical Nuclear Medicine 2011;36:e192-3. [DOI: 10.1097/rlu.0b013e3182291f57] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Guo JW, Zhang XT, Chen XS, Zhang XC, Zheng GJ, Zhang BP, Cai YF. Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: A case report. World J Gastroenterol 2014; 20(8): 2120-2126 [PMID: 24587686 DOI: 10.3748/wjg.v20.i8.2120] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
38 Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, Kim JM, Kim YI, Ryu KW, Kong SH, Kim HI, Jung HY, Kim YS, Zang DY, Cho JY, Park JO, Lim DH, Jung ES, Ahn HS, Kim HJ; Committee on Stomach Cancer Guideline Development. [Synopsis on clinical practice guideline of gastric cancer in Korea: an evidence-based approach]. Korean J Gastroenterol 2014;63:66-81. [PMID: 24561693 DOI: 10.4166/kjg.2014.63.2.66] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
39 Hur H, Kim SH, Kim W, Song KY, Park CH, Jeon HM. The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma. World J Surg Oncol. 2010;8:86. [PMID: 20932345 DOI: 10.1186/1477-7819-8-86] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
40 Zhu W, Xing L, Yue J, Sun X, Sun X, Zhao H, Yu J. Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis. Br J Radiol. 2012;85:e694-e701. [PMID: 22337686 DOI: 10.1259/bjr/29946900] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
41 Park JC, Lee JH, Cheoi K, Chung H, Yun MJ, Lee H, Shin SK, Lee SK, Lee YC. Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor. Eur J Nucl Med Mol Imaging 2012;39:1107-16. [PMID: 22526958 DOI: 10.1007/s00259-012-2116-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
42 Seo HJ, Chung JK, Go H, Cheon GJ, Lee DS. A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report. Clin Nucl Med 2014;39:442-5. [PMID: 24152637 DOI: 10.1097/RLU.0000000000000275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
43 Kim SJ, Cho YS, Moon SH, Bae JM, Kim S, Choe YS, Kim B, Lee K. Primary Tumor 18 F-FDG Avidity Affects the Performance of 18 F-FDG PET/CT for Detecting Gastric Cancer Recurrence. J Nucl Med 2016;57:544-50. [DOI: 10.2967/jnumed.115.163295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
44 Chen B, Feng H, Xie J, Li C, Zhang Y, Wang S. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing 18F-FDG PET/CT-derived parameters. BMC Med Imaging 2020;20:85. [PMID: 32711449 DOI: 10.1186/s12880-020-00486-z] [Reference Citation Analysis]
45 Albers MJ, Bok R, Chen AP, Cunningham CH, Zierhut ML, Zhang VY, Kohler SJ, Tropp J, Hurd RE, Yen YF, Nelson SJ, Vigneron DB, Kurhanewicz J. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res 2008;68:8607-15. [PMID: 18922937 DOI: 10.1158/0008-5472.CAN-08-0749] [Cited by in Crossref: 387] [Cited by in F6Publishing: 253] [Article Influence: 27.6] [Reference Citation Analysis]
46 Zhang Z, Zheng B, Chen W, Xiong H, Jiang C. Accuracy of 18F-FDG PET/CT and CECT for primary staging and diagnosis of recurrent gastric cancer: A meta-analysis. Exp Ther Med 2021;21:164. [PMID: 33456531 DOI: 10.3892/etm.2020.9595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Staniuk T, Zegarski W, Małkowski B, Jankowski M, Klag M, Pietrzak T. Evaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer. Contemp Oncol (Pozn) 2013;17:165-70. [PMID: 23788985 DOI: 10.5114/wo.2013.34621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
48 Hwang SW, Lee DH. Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer? World J Gastroenterol 2014; 20(38): 13775-13782 [PMID: 25320515 DOI: 10.3748/wjg.v20.i38.13775] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
49 Choi BH, Song HS, An YS, Han SU, Kim JH, Yoon JK. Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma. Nucl Med Mol Imaging 2011;45:30-5. [PMID: 24899975 DOI: 10.1007/s13139-010-0058-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
50 Li S, Guo W, Ren G, Huang G, Chen T, Song S. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. British Journal of Oral and Maxillofacial Surgery 2008;46:180-6. [DOI: 10.1016/j.bjoms.2007.11.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
51 Jiang D, Chen X, You Z, Wang H, Zhang X, Li X, Ren S, Huang Q, Hua F, Guan Y, Zhao J, Xie F. Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study. Eur J Nucl Med Mol Imaging 2021. [PMID: 34297193 DOI: 10.1007/s00259-021-05441-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Ma Q, Xin J, Zhao Z, Guo Q, Yu S, Xu W, Liu C, Zhai W. Value of 18F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension. Eur J Radiol. 2013;82:e302-e306. [PMID: 23434453 DOI: 10.1016/j.ejrad.2013.01.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
53 Chen LB, Tong JL, Song HZ, Zhu H, Wang YC. 18F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 2007; 13(37): 5025-5029 [PMID: 17854148 DOI: 10.3748/wjg.v13.i37.5025] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
54 Seevaratnam R, Cardoso R, McGregor C, Lourenco L, Mahar A, Sutradhar R, Law C, Paszat L, Coburn N. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer 2012;15 Suppl 1:S3-18. [PMID: 21837458 DOI: 10.1007/s10120-011-0069-6] [Cited by in Crossref: 110] [Cited by in F6Publishing: 114] [Article Influence: 10.0] [Reference Citation Analysis]
55 Kobayashi H, Nishimura H, Matsumoto K, Yoshida M. Identification of the determinants of 2-deoxyglucose sensitivity in cancer cells by shRNA library screening. Biochem Biophys Res Commun 2015;467:121-7. [PMID: 26403972 DOI: 10.1016/j.bbrc.2015.09.106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
56 Na SJ, o JH, Park JM, Lee HH, Lee SH, Song KY, Choi MG, Park CH. Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer. Oncotarget 2016;7:63968-80. [PMID: 27564108 DOI: 10.18632/oncotarget.11574] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
57 Kwon HW, An L, Kwon HR, Park S, Kim S. Preoperative Nodal 18F-FDG Avidity Rather than Primary Tumor Avidity Determines the Prognosis of Patients with Advanced Gastric Cancer. J Gastric Cancer 2018;18:218-29. [PMID: 30275999 DOI: 10.5230/jgc.2018.18.e23] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
58 Wu CX, Zhu ZH. Diagnosis and evaluation of gastric cancer by positron emission tomography. World J Gastroenterol 2014; 20(16): 4574-4585 [PMID: 24782610 DOI: 10.3748/wjg.v20.i16.4574] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
59 Kwon HR, Pahk K, Park S, Kwon HW, Kim S. Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT. Nucl Med Mol Imaging 2019;53:386-95. [PMID: 31867074 DOI: 10.1007/s13139-019-00622-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
60 Wu WG, Dong P, Wu XS, Li ML, Ding QC, Zhang L, Yang JH, Weng H, Ding Q, Tan ZJ, Lu JH, Gu J, Liu YB. Surgical management of patients with bowel obstructions secondary to gastric cancer. World J Gastroenterol 2013; 19(28): 4559-4567 [PMID: 23901233 DOI: 10.3748/wjg.v19.i28.4559] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Tang C, Pan Q, Xu Z, Zhou X, Wang Y. Gastric schwannoma with giant ulcer and lymphadenopathy mimicking gastric cancer: a case report. BMC Gastroenterol 2020;20:36. [PMID: 32059647 DOI: 10.1186/s12876-020-01186-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kameyama R, Yamamoto Y, Izuishi K, Takebayashi R, Hagiike M, Murota M, Kaji M, Haba R, Nishiyama Y. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2009;36:382-388. [PMID: 18985344 DOI: 10.1007/s00259-008-0970-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
63 Banks KP, Song WS. Role of positron emission tomography-computed tomography in gastrointestinal malignancies. Radiol Clin North Am 2013;51:799-831. [PMID: 24010907 DOI: 10.1016/j.rcl.2013.05.003] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
64 Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Sci. 2008;99:260-266. [PMID: 18271924 DOI: 10.1111/j.1349-7006.2007.00683.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
65 Aichler M, Luber B, Lordick F, Walch A. Proteomic and metabolic prediction of response to therapy in gastric cancer. World J Gastroenterol 2014; 20(38): 13648-13657 [PMID: 25320503 DOI: 10.3748/wjg.v20.i38.13648] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
66 Xu H, Guo R, Xu W, Pan Y, Ma T. 18F-fluorodeoxyglucose positron emission tomography-computed tomography scan after gastric endoscopy in those who present with non-specific symptoms, is it necessary or not? South Asian J Cancer 2017;6:59-63. [PMID: 28702407 DOI: 10.4103/2278-330X.208853] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Kawanaka Y, Kitajima K, Fukushima K, Mouri M, Doi H, Oshima T, Niwa H, Kaibe N, Sasako M, Tomita T, Miwa H, Hirota S. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT. Eur J Radiol 2016;85:989-95. [PMID: 27130061 DOI: 10.1016/j.ejrad.2016.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
68 Yuan LW, Yamashita H, Seto Y. Glucose metabolism in gastric cancer: The cutting-edge. World J Gastroenterol 2016; 22(6): 2046-2059 [PMID: 26877609 DOI: 10.3748/wjg.v22.i6.2046] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
69 Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A Jr, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology 2015;89:305-10. [PMID: 26393501 DOI: 10.1159/000436972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
70 Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T, Kuwano H, Oriuchi N, Endo K. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg. 2005;29:1429-1435. [PMID: 16222452 DOI: 10.1007/s00268-005-0045-6] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
71 Wiehr S, von Ahsen O, Röse L, Mueller A, Mannheim JG, Honndorf V, Kukuk D, Reischl G, Pichler BJ. Preclinical evaluation of a novel c-Met inhibitor in a gastric cancer xenograft model using small animal PET. Mol Imaging Biol 2013;15:203-11. [PMID: 22864665 DOI: 10.1007/s11307-012-0580-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
72 Li P, Liu Q, Wang C, Wang T, Liu J, Huang G, Song S. Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis. Ann Nucl Med. 2016;30:179-187. [PMID: 26830546 DOI: 10.1007/s12149-016-1058-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
73 Kamimura K, Nagamachi S, Wakamatsu H, Fujita S, Nishii R, Umemura Y, Ogita M, Komada N, Sakurai T, Inoue T, Fujimoto T, Nakajo M. Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET. Nucl Med Commun 2009;30:431-9. [PMID: 19352209 DOI: 10.1097/MNM.0b013e3283299a2f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
74 Yun H, Shim K. Role of 18 F 2-fluoro-2-deoxyglucose Positron Emission Tomography in Upper Gastrointestinal Malignancies. Korean J Gastroenterol 2013;61:303. [DOI: 10.4166/kjg.2013.61.6.303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Di Fabio F, Pinto C, Rojas Llimpe FL, Fanti S, Castellucci P, Longobardi C, Mutri V, Funaioli C, Sperandi F, Giaquinta S. The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab. Gastric Cancer. 2007;10:221-227. [PMID: 18095077 DOI: 10.1007/s10120-007-0438-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
76 Kim SK, Kang KW, Lee JS, Kim HK, Chang HJ, Choi JY, Lee JH, Ryu KW, Kim YW, Bae JM. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging. 2006;33:148-155. [PMID: 16228236 DOI: 10.1007/s00259-005-1887-8] [Cited by in Crossref: 122] [Cited by in F6Publishing: 111] [Article Influence: 7.2] [Reference Citation Analysis]
77 Duman K, Simsek A, Gorgulu S, Yagci G, Peker Y. The role of 2-[f-18] fluoro 2-deoxy d-glucose positron emission tomography in the preoperative staging of gastric cancer. Eurasian J Med 2013;45:149-54. [PMID: 25610272 DOI: 10.5152/eajm.2013.32] [Reference Citation Analysis]
78 Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: Comparison with PET and enhanced CT. European Journal of Radiology 2010;73:324-8. [DOI: 10.1016/j.ejrad.2008.10.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
79 Kim J, Lim ST, Na CJ, Han YH, Kim CY, Jeong HJ, Sohn MH. Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer. Nucl Med Mol Imaging. 2014;48:33-40. [PMID: 24900136 DOI: 10.1007/s13139-013-0243-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
80 Karam I, Devic S, Hickeson M, Roberge D, Turcotte RE, Freeman CR. PET/CT for radiotherapy treatment planning in patients with soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2009;75:817-21. [PMID: 19386424 DOI: 10.1016/j.ijrobp.2008.11.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Filik M, Kir KM, Aksel B, Soyda Ç, Özkan E, Küçük ÖN, İbiş E, Akgül H. The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer. Mol Imaging Radionucl Ther 2015;24:15-20. [PMID: 25800593 DOI: 10.4274/mirt.26349] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
82 Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol. 2009;35:449-455. [PMID: 19147324 DOI: 10.1016/j.ejso.2008.11.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
83 Maman A, Sahin A, Ayan AK. The Relationship of SUV Value in PET-CT with Tumor Differentiation and Tumor Markers in Gastric Cancer. Eurasian J Med 2020;52:67-72. [PMID: 32158318 DOI: 10.5152/eurasianjmed.2019.19016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Ott K, Lordick F, Blank S, Büchler M. Gastric cancer: surgery in 2011. Langenbecks Arch Surg 2011;396:743-58. [PMID: 21234760 DOI: 10.1007/s00423-010-0738-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
85 Tao K, Chang W, Zhao E, Deng R, Gao J, Cai K, Wang G, Zhang P. Clinicopathologic Features of Gastric Schwannoma: 8-Year Experience at a Single Institution in China. Medicine (Baltimore). 2015;94:e1970. [PMID: 26559271 DOI: 10.1097/md.0000000000001970] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
86 Oh SY, Cheon GJ, Kim YC, Jeong E, Kim S, Choe JG. Detectability of T-Measurable Diseases in Advanced Gastric Cancer on FDG PET-CT. Nucl Med Mol Imaging 2012;46:261-8. [PMID: 24900073 DOI: 10.1007/s13139-012-0149-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
87 Kim SH, Lee KN, Kang EJ, Kim DW, Hong SH. Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma. Br J Radiol 2012;85:606-12. [PMID: 21304006 DOI: 10.1259/bjr/73516936] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
88 Bilici A, Ustaalioglu BB, Seker M, Kefeli U, Canpolat N, Tekinsoy B, Ozugur S, Gumus M. The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making? Eur J Nucl Med Mol Imaging. 2011;38:64-73. [PMID: 20838995 DOI: 10.1007/s00259-010-1611-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
89 Namikawa T, Okabayshi T, Nogami M, Ogawa Y, Kobayashi M, Hanazaki K. Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer. Int J Clin Oncol 2014;19:649-55. [PMID: 23877653 DOI: 10.1007/s10147-013-0598-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
90 Hasawi NA, Alkandari MF, Luqmani YA. Phosphofructokinase: A mediator of glycolytic flux in cancer progression. Critical Reviews in Oncology/Hematology 2014;92:312-21. [DOI: 10.1016/j.critrevonc.2014.05.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
91 Stephen RM, Gillies RJ. Promise and Progress for Functional and Molecular Imaging of Response to Targeted Therapies. Pharm Res 2007;24:1172-85. [DOI: 10.1007/s11095-007-9250-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
92 Yoo J, Choi JY, Lee KT, Heo JS, Park SB, Moon SH, Choe YS, Lee KH, Kim BT. Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma. Nucl Med Mol Imaging 2012;46:201-6. [PMID: 24900061 DOI: 10.1007/s13139-012-0147-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
93 Brunetto AT, Kristeleit RS, de Bono JS. Early oncology clinical trial design in the era of molecular-targeted agents. Future Oncology 2010;6:1339-52. [DOI: 10.2217/fon.10.92] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
94 Park K, Jang G, Baek S, Song H. Usefulness of Combined PET/CT to Assess Regional Lymph Node Involvement in Gastric Cancer. Tumori 2014;100:201-6. [DOI: 10.1177/030089161410000214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
95 Kruijff S, Bastiaannet E, Brouwers AH, Nagengast WB, Speijers MJ, Suurmeijer AJ, Hospers GA, Hoekstra HJ. Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma. Ann Surg Oncol 2012;19:620-6. [PMID: 21861214 DOI: 10.1245/s10434-011-2027-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
96 Choi JY, Lee KS, Kwon OJ, Shim YM, Baek CH, Park K, Lee KH, Kim BT. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol. 2005;23:7654-7659. [PMID: 16234527 DOI: 10.1200/JCO.2005.01.4340] [Cited by in Crossref: 96] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
97 Nakamoto Y, Togashi K, Kaneta T, Fukuda H, Nakajima K, Kitajima K, Murakami K, Fujii H, Satake M, Tateishi U. Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study. Jpn J Clin Oncol. 2009;39:297-302. [PMID: 19269991 DOI: 10.1093/jjco/hyp010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
98 Archetti M. Heterogeneity and proliferation of invasive cancer subclones in game theory models of the Warburg effect. Cell Prolif 2015;48:259-69. [PMID: 25643821 DOI: 10.1111/cpr.12169] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
99 Heusner TA, Hahn S, Hamami ME, Kim UH, Baumeister R, Forsting M, Stahl A, Bockisch A, Antoch G. Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development. Eur Radiol. 2009;19:2171-2179. [PMID: 19415294 DOI: 10.1007/s00330-009-1405-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
100 Coupe NA, Karikios D, Chong S, Yap J, Ng W, Merrett N, Lin M. Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer. Ann Nucl Med. 2014;28:128-135. [PMID: 24297388 DOI: 10.1007/s12149-013-0791-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
101 Puyraimond-zemmour D, Vignot S. Le métabolisme de la cellule tumorale : l’effet Warburg. Oncologie 2013;15:435-40. [DOI: 10.1007/s10269-013-2318-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
102 Eom BW, Won Ryu K, Man Yoon H, Kook MC. Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer.Chin J Cancer Res. 2020;32:614-620. [PMID: 33223756 DOI: 10.21147/j.issn.1000-9604.2020.05.06] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Schneider PM, Eshmuminov D, Rordorf T, Vetter D, Veit-Haibach P, Weber A, Bauerfeind P, Samaras P, Lehmann K. 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study. BMC Cancer 2018;18:548. [PMID: 29743108 DOI: 10.1186/s12885-018-4477-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
104 Yu L, Tian M, Gao X, Wang D, Qin Y, Geng J. The method and efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing the lymphatic metastasis of colorectal carcinoma. Acad Radiol. 2012;19:427-433. [PMID: 22265721 DOI: 10.1016/j.acra.2011.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
105 Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005;2:98-107. [PMID: 16264882 DOI: 10.1038/ncponc0099] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 6.9] [Reference Citation Analysis]
106 Teixera SR, Kohan AA, Paspulati RM, Rong R, Herrmann KA. Potential Role of Positron Emission Tomography/Magnetic Resonance Imaging in Gastrointestinal and Abdominal Malignancies: Preliminary Experience. Seminars in Roentgenology 2014;49:321-33. [DOI: 10.1053/j.ro.2014.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
107 Chen J, Cheong J, Yun MJ, Kim J, Lim JS, Hyung WJ, Noh SH. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005;103:2383-90. [DOI: 10.1002/cncr.21074] [Cited by in Crossref: 137] [Cited by in F6Publishing: 118] [Article Influence: 8.1] [Reference Citation Analysis]
108 Vergadis C, Schizas D. Is Accurate N - Staging for Gastric Cancer Possible? Front Surg 2018;5:41. [PMID: 29904636 DOI: 10.3389/fsurg.2018.00041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
109 Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R. 18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population. Nucl Med Commun. 2012;33:960-966. [PMID: 22692579 DOI: 10.1097/mnm.0b013e328355b694] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
110 Sim SH, Kim YJ, Oh DY, Lee SH, Kim DW, Kang WJ, Im SA, Kim TY, Kim WH, Heo DS. The role of PET/CT in detection of gastric cancer recurrence. BMC Cancer. 2009;9:73. [PMID: 19250554 DOI: 10.1186/1471-2407-9-73] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
111 Kim EY, Lee WJ, Choi D, Lee SJ, Choi JY, Kim BT, Kim HS. The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol. 2011;79:183-188. [PMID: 20226612 DOI: 10.1016/j.ejrad.2010.02.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
112 Ruiz-hernández G, Delgado-bolton R, Rubio-pérez M, Jiménez-vicioso A, Pérez-castejón M, Carreras-delgado J. Recurrencia de un carcinoma gástrico de células en anillo de sello demostrada por PET-FDG. Revista Española de Medicina Nuclear 2005;24:326-30. [DOI: 10.1157/13079285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Celli R, Colunga M, Patel N, Djekidel M, Jain D. Metabolic Signature on 18F-FDG PET/CT, HER2 Status, and Survival in Gastric Adenocarcinomas. J Nucl Med Technol 2016;44:234-8. [PMID: 27789750 DOI: 10.2967/jnmt.116.181479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
114 Gu J, Yamamoto H, Fukunaga H, Danno K, Takemasa I, Ikeda M, Tatsumi M, Sekimoto M, Hatazawa J, Nishimura T, Monden M. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 2006;51:2198-205. [PMID: 17080242 DOI: 10.1007/s10620-006-9428-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 3.4] [Reference Citation Analysis]
115 McLamore ES, Shi J, Jaroch D, Claussen JC, Uchida A, Jiang Y, Zhang W, Donkin SS, Banks MK, Buhman KK, Teegarden D, Rickus JL, Porterfield DM. A self referencing platinum nanoparticle decorated enzyme-based microbiosensor for real time measurement of physiological glucose transport. Biosens Bioelectron 2011;26:2237-45. [PMID: 20965716 DOI: 10.1016/j.bios.2010.09.041] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
116 Obermannova R, Selingerova I, Rehak Z, Jedlicka V, Slavik M, Fabian P, Novotny I, Zemanova M, Studentova H, Grell P, Zdrazilova Dubska L, Demlova R, Harustiak T, Hejnova R, Kiss I, Vyzula R. PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study. Ther Adv Med Oncol 2021;13:17588359211065153. [PMID: 35035533 DOI: 10.1177/17588359211065153] [Reference Citation Analysis]
117 Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging. 2009;34:441-447. [PMID: 18543017 DOI: 10.1007/s00261-008-9424-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
118 Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, Kim JM, Kim YI, Ryu KW, Kong SH, Kim HI, Jung HY, Kim YS, Zang DY, Cho JY, Park JO, Lim DH, Jung ES, Ahn HS, Kim HJ. Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer. 2014;14:87-104. [PMID: 25061536 DOI: 10.5230/jgc.2014.14.2.87] [Cited by in Crossref: 119] [Cited by in F6Publishing: 118] [Article Influence: 14.9] [Reference Citation Analysis]
119 Smyth E, Schöder H, Strong VE, Capanu M, Kelsen DP, Coit DG, Shah MA. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012;118:5481-5488. [PMID: 22549558 DOI: 10.1002/cncr.27550] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 7.3] [Reference Citation Analysis]
120 Kaida H, Ishibashi M, Nakamura M, Baba K, Tahara N, Uozumi J, Tomita N, Arikawa S, Hayabuchi N. Early gastric cancer and early colon cancer detected simultaneously by PET cancer screening incidentally. Ann Nucl Med 2006;20:317-20. [DOI: 10.1007/bf02984649] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
121 Liu Y, Zheng D, Liu JJ, Cui JX, Xi HQ, Zhang KC, Huang XH, Wei B, Wang XX, Xu BX, Li K, Gao YH, Liang WQ, Tian JH, Chen L. Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer. Gastroenterol Res Pract 2019;2019:9564627. [PMID: 30863443 DOI: 10.1155/2019/9564627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
122 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
123 Aihara R, Mochiki E, Ohotake S, Kamiyama Y, Ohono T, Kuwano H, Kurokawa K, Suzuki K. Peritoneal recurrence of gastric cancer with mucin phenotype 12 years after curative resection: report of a case. Surg Today 2007;37:325-9. [PMID: 17387567 DOI: 10.1007/s00595-006-3392-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
124 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
125 Talbot J, Montravers F, Gutman F, Kerrou K, Huchet V, Grahek D, Andre T, Houry S, Touboul E, Rosmorduc O, Poupon R, Ruszniewski P, Rougier P, Grange J. Tomographie par émission de positons et cancers digestifs. La Presse Médicale 2008;37:e1-e24. [DOI: 10.1016/j.lpm.2007.03.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
126 Mukai K, Ishida Y, Okajima K, Isozaki H, Morimoto T, Nishiyama S. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer. 2006;9:192-196. [PMID: 16952037 DOI: 10.1007/s10120-006-0374-7] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 7.1] [Reference Citation Analysis]
127 Lee JW, Jo K, Cho A, Noh SH, Lee JD, Yun M. Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer. J Nucl Med. 2015;56:1494-1500. [PMID: 26251414 DOI: 10.2967/jnumed.115.160580] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
128 Yamada A, Oguchi K, Fukushima M, Imai Y, Kadoya M. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann Nucl Med. 2006;20:597-604. [PMID: 17294670 DOI: 10.1007/bf02984657] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
129 Wu Z, Zhao J, Gao P, Song Y, Sun J, Chen X, Ma B, Wang Z. Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis. BMC Cancer 2017;17:275. [PMID: 28415990 DOI: 10.1186/s12885-017-3271-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
130 Lee JW, Lee SM, Lee MS, Shin HC. Role of 18F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection. Eur J Nucl Med Mol Imaging. 2012;39:1425-1434. [PMID: 22673973 DOI: 10.1007/s00259-012-2164-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
131 Choi JY, Shim KN, Kim SE, Jung HK, Jung SA, Yoo K. The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma. Korean J Gastroenterol 2014;64:340-7. [PMID: 25530585 DOI: 10.4166/kjg.2014.64.6.340] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
132 Ohno T, Ogata K, Kogure N, Ando H, Aihara R, Mochiki E, Zai H, Sano A, Kato T, Sakurai S, Oyama T, Asao T, Kuwano H. Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases. Surg Today. 2011;41:1133-1137. [PMID: 21773906 DOI: 10.1007/s00595-010-4401-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
133 Smyth EC, Shah MA. Role of (18F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World J Gastroenterol 2011; 17(46): 5059-5074 [PMID: 22171140 DOI: 10.3748/wjg.v17.i46.5059] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
134 Choi BW, Zeon SK, Kim SH, Jo I, Kim HW, Won KS. Significance of SUV on Follow-up F-18 FDG PET at the Anastomotic Site of Gastroduodenostomy after Distal Subtotal Gastrectomy in Patients with Gastric Cancer. Nucl Med Mol Imaging 2011;45:285-90. [PMID: 24900019 DOI: 10.1007/s13139-011-0105-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
135 Serrano OK, Love C, Goldman I, Huang K, Ng N, Abraham T, Da Silva R, Friedmann P, Libutti SK, Kennedy TJ. The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review. J Surg Oncol. 2016;113:640-646. [PMID: 27115836 DOI: 10.1002/jso.24190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
136 Yun M. Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT. J Gastric Cancer. 2014;14:1-6. [PMID: 24765531 DOI: 10.5230/jgc.2014.14.1.1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
137 Kang S, Ahn B, Hong C, Song B, Lee H, Jeong S, Lee S, Lee J, Lee S. Can 18F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma? Nuklearmedizin 2017;50:116-21. [DOI: 10.3413/nukmed-0356-10-09] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
138 Wang J, Zhang S, Li Z, Yang J, Huang C, Liang R, Liu Z, Zhou R. 1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis. Tumor Biol 2011;32:223-31. [DOI: 10.1007/s13277-010-0116-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
139 Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Inoue T. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey. Jpn J Radiol 2014;32:253-9. [DOI: 10.1007/s11604-014-0294-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
140 Yang DM, Kim HC, Jin W, Ryu CW, Kang JH, Park CH, Kim HS, Jung DH. 64 multidetector-row computed tomography for preoperative evaluation of gastric cancer: histological correlation. J Comput Assist Tomogr 2007;31:98-103. [PMID: 17259840 DOI: 10.1097/01.rct.0000234072.16209.ab] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
141 Dondi F, Albano D, Giubbini R, Bertagna F. 18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review. Nucl Med Commun 2021;42:1293-300. [PMID: 34456317 DOI: 10.1097/MNM.0000000000001481] [Reference Citation Analysis]
142 Lee SJ, Lee WW, Yoon HJ, Lee HY, Lee KH, Kim YH, Park DJ, Kim HH, So Y, Kim SE. Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer. Eur J Radiol 2013;82:935-42. [PMID: 23410909 DOI: 10.1016/j.ejrad.2013.01.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
143 Speijers MJ, Francken AB, Hoekstra-weebers JE, Bastiaannet E, Kruijff S, Hoekstra HJ. Optimal follow-up for melanoma. Expert Review of Dermatology 2014;5:461-78. [DOI: 10.1586/edm.10.38] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
144 Fu L, Li H, Wang H, Xu B, Fan Y, Tian J. SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma. PLoS One. 2012;7:e50914. [PMID: 23226547 DOI: 10.1371/journal.pone.0050914] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
145 Coller HA. Is cancer a metabolic disease? Am J Pathol 2014;184:4-17. [PMID: 24139946 DOI: 10.1016/j.ajpath.2013.07.035] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 12.8] [Reference Citation Analysis]
146 Park S, Lee D, Lee KM, Han S, Lee JH, Lee SJ, An Y, Yoon J. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma. European Journal of Radiology 2017;94:160-6. [DOI: 10.1016/j.ejrad.2017.06.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
147 Hoppo T, Jobe BA. Endoscopy and role of endoscopic resection in gastric cancer. J Surg Oncol. 2013;107:243-249. [PMID: 22532029 DOI: 10.1002/jso.23126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
148 Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9. [PMID: 15516961 DOI: 10.1038/nrc1478] [Cited by in Crossref: 3045] [Cited by in F6Publishing: 2861] [Article Influence: 169.2] [Reference Citation Analysis]
149 Kurhanewicz J, Vigneron DB. Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am. 2008;16:697-710, ix-x. [PMID: 18926432 DOI: 10.1016/j.mric.2008.07.005] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 5.7] [Reference Citation Analysis]
150 Leite TC, Watters RJ, Weiss KR, Intini G. Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma. J Transl Med 2021;19:450. [PMID: 34715874 DOI: 10.1186/s12967-021-03122-8] [Reference Citation Analysis]
151 Ciarallo A, Marcus C, Taghipour M, Subramaniam RM. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer. PET Clinics 2015;10:265-78. [DOI: 10.1016/j.cpet.2014.12.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
152 Montravers F, Grahek D, Kerrou K, Gutman F, Talbot JN. [Positron emission tomography (PET) in gastrointestinal cancer]. Gastroenterol Clin Biol 2006;30:737-41. [PMID: 16801895 DOI: 10.1016/s0399-8320(06)73306-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Jo HJ, Kim SJ, Kim IJ, Kim S. Predictive value of volumetric parameters measured by F-18 FDG PET/CT for lymph node status in patients with surgically resected rectal cancer. Ann Nucl Med 2014;28:196-202. [PMID: 24532377 DOI: 10.1007/s12149-014-0809-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
154 Shida A, Mitsumori N, Nimura H, Takano Y, Iwasaki T, Fujisaki M, Takahashi N, Yanaga K. Prediction of lymph node metastasis and sentinel node navigation surgery for patients with early-stage gastric cancer. World J Gastroenterol 2016; 22(33): 7431-7439 [PMID: 27672266 DOI: 10.3748/wjg.v22.i33.7431] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
155 Bae SW, Berlth F, Jeong KY, Park JH, Choi JH, Park SH, Suh YS, Kong SH, Park DJ, Lee HJ, Lee C, Kim JI, Youn H, Choi H, Cheon GJ, Kang KW, Yang HK. Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer. Gastric Cancer 2021. [PMID: 34363529 DOI: 10.1007/s10120-021-01223-3] [Reference Citation Analysis]
156 Clark CJ, Thirlby RC, Picozzi V, Schembre DB, Cummings FP, Lin E. Current problems in surgery: gastric cancer. Curr Probl Surg. 2006;43:566-670. [PMID: 17000267 DOI: 10.1067/j.cpsurg.2006.06.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
157 Chen Y, Bei J, Liu M, Huang J, Xie L, Huang W, Cai M, Guo Y, Lin L, Zhu K. Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation. Cancer Lett 2021;518:23-34. [PMID: 34126196 DOI: 10.1016/j.canlet.2021.06.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]